SERINC3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.96999999985326E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
7.2967000219748E-09 |
Normal-vs-Stage2 |
1.178980E-01 |
Normal-vs-Stage3 |
9.886400E-01 |
Normal-vs-Stage4 |
5.976600E-01 |
Stage1-vs-Stage2 |
2.936800E-01 |
Stage1-vs-Stage3 |
3.453900E-02 |
Stage1-vs-Stage4 |
3.623200E-01 |
Stage2-vs-Stage3 |
3.000000E-01 |
Stage2-vs-Stage4 |
7.066600E-01 |
Stage3-vs-Stage4 |
6.551000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.14389999997344E-06 |
Normal-vs-AfricanAmerican |
5.93620000000072E-05 |
Normal-vs-Asian |
2.463100E-03 |
Caucasian-vs-AfricanAmerican |
5.463600E-01 |
Caucasian-vs-Asian |
7.761800E-01 |
AfricanAmerican-vs-Asian |
9.308600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.26329963051819E-10 |
Normal-vs-Female |
6.331800E-01 |
Male-vs-Female |
1.520560E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
7.615900E-03 |
Normal-vs-Extreme_Weight |
1.07699960061325E-10 |
Normal-vs-Obese |
1.091170E-01 |
Normal-vs-Extreme_Obese |
1.024500E-03 |
Normal_Weight-vs-Extreme_Weight |
1.984000E-01 |
Normal_Weight-vs-Obese |
2.782400E-01 |
Normal_Weight-vs-Extreme_Obese |
2.609800E-01 |
Extreme_Weight-vs-Obese |
4.299300E-03 |
Extreme_Weight-vs-Extreme_Obese |
4.969600E-01 |
Obese-vs-Extreme_Obese |
7.672100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
8.178600E-01 |
Normal-vs-Age(41-60Yrs) |
5.616000E-03 |
Normal-vs-Age(61-80Yrs) |
4.02260003085075E-10 |
Normal-vs-Age(81-100Yrs) |
1.30539999920742E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.651420E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.687900E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.550400E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.152000E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.680710E-03 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.387220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
8.44646574904573E-12 |
Normal-VS-Type2 PRCC |
1.077750E-03 |
Normal-VS-KIRP CIMP |
8.414100E-02 |
Normal-VS-Unclassified PRCC |
9.423000E-01 |
Type1 PRCC-VS-Type2 PRCC |
6.822400E-02 |
Type1 PRCC-VS-KIRP CIMP |
9.458200E-03 |
Type1 PRCC-VS-Unclassified PRCC |
1.681890E-03 |
Type2 PRCC-VS-KIRP CIMP |
2.194400E-02 |
Type2 PRCC-VS-Unclassified PRCC |
3.466300E-02 |
KIRP CIMP-VS-Unclassified PRCC |
3.774100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.575960E-04 |
Normal-vs-N1 |
6.216200E-01 |
Normal-vs-N2 |
6.945200E-01 |
N0-vs-N1 |
7.256200E-03 |
N0-vs-N2 |
7.673600E-02 |
N1-vs-N2 |
7.563400E-01 |
|
|